Today’s myeloma therapy can effectively kill myeloma in many patients and even make them minimal residual disease negative. But then years later, it can grow back. How is this possible? University of Iowa researchers and colleagues are working to identify which cells are “tumor-initiating” or cause myeloma to grow. In a recent paper, the researchers[...]

David Chung, MD, PhD Memorial Sloan Kettering Cancer Center Interview Date: November 19, 2018 Summary Why do some multiple myeloma patients relapse early after stem cell transplant while others stay in remission for many years? The patient’s immune system may be a key factor.   David Chung, MD, PhD of Memorial Sloan Kettering Cancer Center was[...]

  The first Myeloma Crowd Research Initiative (MCRI) successfully raised $500,000 for two immunotherapy research projects for high-risk myeloma (CAR T and T cell treatments). Now, the MCRI will fund research to match the right treatment with the right patient at the right time.  A small fraction of multiple myeloma patients may already be cured[...]

Monday, November 19, 2018 @ 10 am Pacific, 11 am Mountain, Noon Central, 1 pm Eastern Call In by Phone to Listen Live: (347) 637-2631 or Listen Live Via Computer Why do some multiple myeloma patients relapse early after stem cell transplant while others stay in remission for many years? The patient’s immune system may be[...]

In 2015 the Myeloma Crowd had a hypothesis: If patients collaborated with myeloma experts, we could accelerate a cure. Our dream has become a reality with the success of the first Myeloma Crowd Research Initiative (MCRI) campaign. Our recent announcement was shared here. The MCRI is the first patient-led crowdsourcing and crowdfunding initiative for multiple myeloma[...]

The Myeloma Crowd Initiative selected two proposals it has selected for the MCRI crowdsourcing and patient-led funding initiative. This is the first time that a united group of patients have joined with myeloma researchers to find and fund a cure for high-risk myeloma. “The study of high-risk myeloma should be one of the top priorities[...]

Richard Hite is a myeloma patient who can’t wait for a cure. Can you? Because only 1 in 12 research proposals are funded by the NCI, we decided that it was time patients pitch in to help speed a cure for themselves. It typically takes 10 years to bring a new treatment to the clinic.[...]

BY LIZZY SMITH Every morning in Africa, a gazelle wakes up. It knows it must run faster than the fastest lion or it will be killed. Every morning a lion wakes up. It knows it must outrun the slowest gazelle or it will starve to death. Not long ago, I heard Dr Rafael Fonseca of Mayo[...]

For Wendy Reif, jewelry making will forever be linked with myeloma. It all started in 2014, not long after Wendy’s husband learned he would start treatment for multiple myeloma (he was diagnosed as “smoldering” two years prior). That’s when Wendy took a jewelry making class as “caregiver therapy,” joining a few of her closest friends[...]

The Myeloma Crowd Research Initiative (MCRI) is off to a fabulous start, so far raising $500,000. Our next project is an online fundraising auction. We are asking you, our myeloma family, to consider donating something of value for this critically important project. Here’s how it works: 1. Send a description and quality photo of the[...]